nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—Signaling Pathways—GNA13—hematologic cancer	0.00049	0.00207	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SPHK1—hematologic cancer	0.000488	0.00206	CbGpPWpGaD
Gentamicin—LRP2—Disease—MTR—hematologic cancer	0.000485	0.00205	CbGpPWpGaD
Gentamicin—LRP2—Disease—XIAP—hematologic cancer	0.000485	0.00205	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TIAM1—hematologic cancer	0.000482	0.00204	CbGpPWpGaD
Gentamicin—LRP2—Disease—ENO2—hematologic cancer	0.000476	0.00201	CbGpPWpGaD
Gentamicin—LRP2—Disease—SMARCA4—hematologic cancer	0.000473	0.002	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—UGT1A1—hematologic cancer	0.000469	0.00198	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—JAK3—hematologic cancer	0.000468	0.00197	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000458	0.00193	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SLC22A1—hematologic cancer	0.000456	0.00192	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CRABP1—hematologic cancer	0.000456	0.00192	CbGpPWpGaD
Gentamicin—LRP2—Disease—SDC1—hematologic cancer	0.000451	0.0019	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCL13—hematologic cancer	0.000448	0.00189	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCR7—hematologic cancer	0.000448	0.00189	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ALOX5—hematologic cancer	0.000444	0.00188	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NCOR2—hematologic cancer	0.000442	0.00187	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL3RA—hematologic cancer	0.000437	0.00184	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CRKL—hematologic cancer	0.000437	0.00184	CbGpPWpGaD
Gentamicin—LRP2—Disease—LCK—hematologic cancer	0.000437	0.00184	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NUP98—hematologic cancer	0.00043	0.00182	CbGpPWpGaD
Gentamicin—LRP2—Disease—H3F3A—hematologic cancer	0.000428	0.00181	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RGS2—hematologic cancer	0.000422	0.00178	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ADCY7—hematologic cancer	0.000418	0.00176	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NCOA3—hematologic cancer	0.000418	0.00176	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TRH—hematologic cancer	0.000417	0.00176	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CMA1—hematologic cancer	0.000417	0.00176	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TRIO—hematologic cancer	0.000417	0.00176	CbGpPWpGaD
Gentamicin—LRP2—Disease—PRKCZ—hematologic cancer	0.000416	0.00176	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NUP214—hematologic cancer	0.000415	0.00175	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	0.00041	0.00173	CbGpPWpGaD
Gentamicin—LRP2—Disease—CALR—hematologic cancer	0.000409	0.00173	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SPHK1—hematologic cancer	0.000408	0.00172	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AGO2—hematologic cancer	0.000408	0.00172	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ABCG2—hematologic cancer	0.000406	0.00172	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—MTR—hematologic cancer	0.000406	0.00172	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LPAR1—hematologic cancer	0.000404	0.0017	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HDAC9—hematologic cancer	0.000404	0.0017	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000402	0.0017	CbGpPWpGaD
Gentamicin—LRP2—Disease—PARP1—hematologic cancer	0.000402	0.0017	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—H3F3B—hematologic cancer	0.0004	0.00169	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ENO2—hematologic cancer	0.000398	0.00168	CbGpPWpGaD
Gentamicin—LRP2—Disease—FBXW7—hematologic cancer	0.000396	0.00167	CbGpPWpGaD
Gentamicin—LRP2—Disease—CXCR4—hematologic cancer	0.000388	0.00164	CbGpPWpGaD
Gentamicin—LRP2—Disease—HDAC2—hematologic cancer	0.000388	0.00164	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTT1—hematologic cancer	0.000386	0.00163	CbGpPWpGaD
Gentamicin—LRP2—Disease—CD44—hematologic cancer	0.000384	0.00162	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	0.000381	0.00161	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.00038	0.0016	CbGpPWpGaD
Gentamicin—LRP2—Disease—CBL—hematologic cancer	0.000378	0.0016	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SDC1—hematologic cancer	0.000378	0.00159	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000373	0.00157	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PDE4B—hematologic cancer	0.000371	0.00157	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CNR2—hematologic cancer	0.000371	0.00157	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGF19—hematologic cancer	0.000368	0.00156	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000366	0.00154	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RAC2—hematologic cancer	0.000365	0.00154	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—DKK1—hematologic cancer	0.000363	0.00153	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	0.000361	0.00152	CbGpPWpGaD
Gentamicin—LRP2—Disease—HSP90AA1—hematologic cancer	0.000361	0.00152	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT5B—hematologic cancer	0.00036	0.00152	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	0.000356	0.0015	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ADCY7—hematologic cancer	0.000349	0.00147	CbGpPWpGaD
Gentamicin—LRP2—Disease—STAT1—hematologic cancer	0.000348	0.00147	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000347	0.00146	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	0.000341	0.00144	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—XIAP—hematologic cancer	0.00034	0.00143	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SH2B3—hematologic cancer	0.000331	0.0014	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SMARCA4—hematologic cancer	0.000331	0.0014	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GZMB—hematologic cancer	0.000329	0.00139	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000326	0.00138	CbGpPWpGaD
Gentamicin—LRP2—Disease—GRB2—hematologic cancer	0.000325	0.00137	CbGpPWpGaD
Gentamicin—LRP2—Disease—PDGFA—hematologic cancer	0.000325	0.00137	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CTNNA1—hematologic cancer	0.000321	0.00136	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NQO1—hematologic cancer	0.000321	0.00136	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CD44—hematologic cancer	0.000321	0.00136	CbGpPWpGaD
Gentamicin—LRP2—Disease—KITLG—hematologic cancer	0.00032	0.00135	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HSPB1—hematologic cancer	0.000319	0.00135	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EIF4EBP1—hematologic cancer	0.000319	0.00135	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCL3—hematologic cancer	0.000319	0.00135	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SDC1—hematologic cancer	0.000316	0.00133	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTHLH—hematologic cancer	0.000316	0.00133	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	0.000315	0.00133	CbGpPWpGaD
Gentamicin—LRP2—Disease—STAT5A—hematologic cancer	0.000313	0.00132	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN2B—hematologic cancer	0.00031	0.00131	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000309	0.0013	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTGER4—hematologic cancer	0.000307	0.0013	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LCK—hematologic cancer	0.000306	0.00129	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYCS—hematologic cancer	0.000304	0.00128	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HSP90AA1—hematologic cancer	0.000302	0.00127	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—H3F3A—hematologic cancer	0.0003	0.00127	CbGpPWpGaD
Gentamicin—LRP2—Disease—CD86—hematologic cancer	0.0003	0.00127	CbGpPWpGaD
Gentamicin—LRP2—Disease—HES1—hematologic cancer	0.000296	0.00125	CbGpPWpGaD
Gentamicin—LRP2—Disease—NCOR1—hematologic cancer	0.000294	0.00124	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PRKCZ—hematologic cancer	0.000291	0.00123	CbGpPWpGaD
Gentamicin—LRP2—Disease—FGF1—hematologic cancer	0.000291	0.00123	CbGpPWpGaD
Gentamicin—LRP2—Disease—FOXO1—hematologic cancer	0.000286	0.00121	CbGpPWpGaD
Gentamicin—LRP2—Disease—PDGFRB—hematologic cancer	0.000286	0.00121	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000283	0.00119	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000283	0.00119	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000283	0.00119	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PARP1—hematologic cancer	0.000282	0.00119	CbGpPWpGaD
Gentamicin—LRP2—Disease—PDGFRA—hematologic cancer	0.000281	0.00119	CbGpPWpGaD
Gentamicin—LRP2—Disease—JAK1—hematologic cancer	0.000281	0.00118	CbGpPWpGaD
Gentamicin—LRP2—Disease—PRKCG—hematologic cancer	0.000281	0.00118	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FBXW7—hematologic cancer	0.000277	0.00117	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	0.000272	0.00115	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HDAC2—hematologic cancer	0.000272	0.00115	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCR4—hematologic cancer	0.000272	0.00115	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTP1—hematologic cancer	0.000268	0.00113	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CBL—hematologic cancer	0.000265	0.00112	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL3—hematologic cancer	0.000262	0.00111	CbGpPWpGaD
Gentamicin—LRP2—Disease—MTHFR—hematologic cancer	0.00026	0.0011	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	0.000259	0.00109	CbGpPWpGaD
Gentamicin—LRP2—Disease—TERT—hematologic cancer	0.000259	0.00109	CbGpPWpGaD
Gentamicin—LRP2—Disease—HLA-A—hematologic cancer	0.000259	0.00109	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTPN1—hematologic cancer	0.000257	0.00109	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000255	0.00107	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ABCB1—hematologic cancer	0.000254	0.00107	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RASGRP1—hematologic cancer	0.000253	0.00107	CbGpPWpGaD
Gentamicin—LRP2—Disease—PDGFB—hematologic cancer	0.000253	0.00107	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HSP90AA1—hematologic cancer	0.000253	0.00107	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SYK—hematologic cancer	0.000253	0.00107	CbGpPWpGaD
Gentamicin—LRP2—Disease—TSC2—hematologic cancer	0.000247	0.00104	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTM1—hematologic cancer	0.000246	0.00104	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NCOR1—hematologic cancer	0.000246	0.00104	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT1—hematologic cancer	0.000243	0.00103	CbGpPWpGaD
Gentamicin—LRP2—Disease—FGFR3—hematologic cancer	0.000238	0.001	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GRB2—hematologic cancer	0.000228	0.000962	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PDGFA—hematologic cancer	0.000227	0.000959	CbGpPWpGaD
Gentamicin—LRP2—Disease—BAD—hematologic cancer	0.000225	0.000951	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KITLG—hematologic cancer	0.000224	0.000946	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000223	0.000943	CbGpPWpGaD
Gentamicin—LRP2—Disease—NOTCH1—hematologic cancer	0.000223	0.000942	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT5A—hematologic cancer	0.000219	0.000924	CbGpPWpGaD
Gentamicin—LRP2—Disease—CD80—hematologic cancer	0.000219	0.000923	CbGpPWpGaD
Gentamicin—LRP2—Disease—KIT—hematologic cancer	0.000218	0.000922	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—MTHFR—hematologic cancer	0.000218	0.000919	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN2B—hematologic cancer	0.000217	0.000916	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTPN11—hematologic cancer	0.000214	0.000905	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CD86—hematologic cancer	0.00021	0.000886	CbGpPWpGaD
Gentamicin—LRP2—Disease—CREB1—hematologic cancer	0.000208	0.000877	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HES1—hematologic cancer	0.000207	0.000874	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NCOR1—hematologic cancer	0.000206	0.000869	CbGpPWpGaD
Gentamicin—LRP2—Disease—BRAF—hematologic cancer	0.000205	0.000866	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000204	0.000863	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGF1—hematologic cancer	0.000204	0.000859	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CSF2—hematologic cancer	0.000204	0.000859	CbGpPWpGaD
Gentamicin—LRP2—Disease—IL6R—hematologic cancer	0.000203	0.000856	CbGpPWpGaD
Gentamicin—LRP2—Disease—CREBBP—hematologic cancer	0.000202	0.000854	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FOXO1—hematologic cancer	0.000201	0.000847	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PDGFRB—hematologic cancer	0.0002	0.000845	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PDGFRA—hematologic cancer	0.000197	0.000832	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—JAK1—hematologic cancer	0.000196	0.000829	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PRKCG—hematologic cancer	0.000196	0.000829	CbGpPWpGaD
Gentamicin—LRP2—Disease—MAP2K1—hematologic cancer	0.000193	0.000815	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000193	0.000814	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CD—hematologic cancer	0.000192	0.00081	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	0.000192	0.000809	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000187	0.000791	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000186	0.000785	CbGpPWpGaD
Gentamicin—LRP2—Disease—FGF2—hematologic cancer	0.000184	0.000776	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL2RA—hematologic cancer	0.000183	0.000775	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CG—hematologic cancer	0.000183	0.000772	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000182	0.000769	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TERT—hematologic cancer	0.000181	0.000766	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3R1—hematologic cancer	0.000181	0.000765	CbGpPWpGaD
Gentamicin—Paraesthesia—Etoposide—hematologic cancer	0.00018	0.000236	CcSEcCtD
Gentamicin—Pruritus—Ifosfamide—hematologic cancer	0.000179	0.000235	CcSEcCtD
Gentamicin—Weight decreased—Epirubicin—hematologic cancer	0.000179	0.000234	CcSEcCtD
Gentamicin—Alopecia—Prednisone—hematologic cancer	0.000179	0.000234	CcSEcCtD
Gentamicin—Dizziness—Thalidomide—hematologic cancer	0.000178	0.000234	CcSEcCtD
Gentamicin—Nausea—Bortezomib—hematologic cancer	0.000178	0.000233	CcSEcCtD
Gentamicin—Hypersensitivity—Irinotecan—hematologic cancer	0.000177	0.000233	CcSEcCtD
Gentamicin—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000177	0.000233	CcSEcCtD
Gentamicin—Paraesthesia—Prednisolone—hematologic cancer	0.000177	0.000233	CcSEcCtD
Gentamicin—Vomiting—Thiotepa—hematologic cancer	0.000177	0.000232	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PDGFB—hematologic cancer	0.000177	0.000748	CbGpPWpGaD
Gentamicin—Nausea—Bleomycin—hematologic cancer	0.000176	0.000231	CcSEcCtD
Gentamicin—LRP2—Disease—JAK2—hematologic cancer	0.000176	0.000743	CbGpPWpGaD
Gentamicin—Erythema—Prednisone—hematologic cancer	0.000176	0.000231	CcSEcCtD
Gentamicin—Rash—Thiotepa—hematologic cancer	0.000176	0.00023	CcSEcCtD
Gentamicin—Dermatitis—Thiotepa—hematologic cancer	0.000176	0.00023	CcSEcCtD
Gentamicin—Agranulocytosis—Methotrexate—hematologic cancer	0.000176	0.00023	CcSEcCtD
Gentamicin—Convulsion—Betamethasone—hematologic cancer	0.000175	0.000229	CcSEcCtD
Gentamicin—Convulsion—Dexamethasone—hematologic cancer	0.000175	0.000229	CcSEcCtD
Gentamicin—Headache—Thiotepa—hematologic cancer	0.000175	0.000229	CcSEcCtD
Gentamicin—Hypertension—Dexamethasone—hematologic cancer	0.000174	0.000229	CcSEcCtD
Gentamicin—Hypertension—Betamethasone—hematologic cancer	0.000174	0.000229	CcSEcCtD
Gentamicin—Decreased appetite—Etoposide—hematologic cancer	0.000174	0.000228	CcSEcCtD
Gentamicin—Nausea—Vinorelbine—hematologic cancer	0.000173	0.000227	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—TSC2—hematologic cancer	0.000173	0.000731	CbGpPWpGaD
Gentamicin—Body temperature increased—Cisplatin—hematologic cancer	0.000173	0.000227	CcSEcCtD
Gentamicin—Neuropathy peripheral—Epirubicin—hematologic cancer	0.000173	0.000226	CcSEcCtD
Gentamicin—LRP2—Disease—MDM2—hematologic cancer	0.000172	0.000726	CbGpPWpGaD
Gentamicin—Stomatitis—Epirubicin—hematologic cancer	0.000172	0.000225	CcSEcCtD
Gentamicin—Vomiting—Thalidomide—hematologic cancer	0.000172	0.000225	CcSEcCtD
Gentamicin—Dizziness—Carmustine—hematologic cancer	0.000171	0.000225	CcSEcCtD
Gentamicin—Rash—Thalidomide—hematologic cancer	0.00017	0.000223	CcSEcCtD
Gentamicin—Dermatitis—Thalidomide—hematologic cancer	0.00017	0.000223	CcSEcCtD
Gentamicin—Dizziness—Alitretinoin—hematologic cancer	0.00017	0.000222	CcSEcCtD
Gentamicin—LRP2—Metabolism—CREBBP—hematologic cancer	0.000169	0.000716	CbGpPWpGaD
Gentamicin—Headache—Thalidomide—hematologic cancer	0.000169	0.000221	CcSEcCtD
Gentamicin—Dizziness—Ifosfamide—hematologic cancer	0.000168	0.00022	CcSEcCtD
Gentamicin—LRP2—Disease—PIK3CB—hematologic cancer	0.000167	0.000706	CbGpPWpGaD
Gentamicin—LRP2—Disease—MTOR—hematologic cancer	0.000167	0.000706	CbGpPWpGaD
Gentamicin—LRP2—Disease—CD4—hematologic cancer	0.000167	0.000705	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGFR3—hematologic cancer	0.000166	0.000703	CbGpPWpGaD
Gentamicin—Pruritus—Gemcitabine—hematologic cancer	0.000166	0.000218	CcSEcCtD
Gentamicin—Nausea—Thiotepa—hematologic cancer	0.000166	0.000217	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000166	0.000217	CcSEcCtD
Gentamicin—Weight decreased—Doxorubicin—hematologic cancer	0.000165	0.000217	CcSEcCtD
Gentamicin—Feeling abnormal—Etoposide—hematologic cancer	0.000165	0.000216	CcSEcCtD
Gentamicin—Anaphylactic shock—Betamethasone—hematologic cancer	0.000165	0.000216	CcSEcCtD
Gentamicin—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000165	0.000216	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—MAPK14—hematologic cancer	0.000165	0.000696	CbGpPWpGaD
Gentamicin—Vomiting—Carmustine—hematologic cancer	0.000165	0.000216	CcSEcCtD
Gentamicin—Agranulocytosis—Epirubicin—hematologic cancer	0.000164	0.000215	CcSEcCtD
Gentamicin—Dizziness—Vincristine—hematologic cancer	0.000164	0.000214	CcSEcCtD
Gentamicin—Rash—Carmustine—hematologic cancer	0.000163	0.000214	CcSEcCtD
Gentamicin—Dermatitis—Carmustine—hematologic cancer	0.000163	0.000214	CcSEcCtD
Gentamicin—Vomiting—Alitretinoin—hematologic cancer	0.000163	0.000214	CcSEcCtD
Gentamicin—Paraesthesia—Triamcinolone—hematologic cancer	0.000163	0.000214	CcSEcCtD
Gentamicin—Feeling abnormal—Prednisolone—hematologic cancer	0.000163	0.000213	CcSEcCtD
Gentamicin—Visual impairment—Methotrexate—hematologic cancer	0.000163	0.000213	CcSEcCtD
Gentamicin—Anaemia—Prednisone—hematologic cancer	0.000163	0.000213	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000162	0.000685	CbGpPWpGaD
Gentamicin—Headache—Carmustine—hematologic cancer	0.000162	0.000213	CcSEcCtD
Gentamicin—Rash—Alitretinoin—hematologic cancer	0.000162	0.000212	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ESR1—hematologic cancer	0.000162	0.000683	CbGpPWpGaD
Gentamicin—Dermatitis—Alitretinoin—hematologic cancer	0.000162	0.000212	CcSEcCtD
Gentamicin—Thrombocytopenia—Betamethasone—hematologic cancer	0.000161	0.000212	CcSEcCtD
Gentamicin—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000161	0.000212	CcSEcCtD
Gentamicin—Vomiting—Ifosfamide—hematologic cancer	0.000161	0.000211	CcSEcCtD
Gentamicin—Hypersensitivity—Cisplatin—hematologic cancer	0.000161	0.000211	CcSEcCtD
Gentamicin—Headache—Alitretinoin—hematologic cancer	0.000161	0.000211	CcSEcCtD
Gentamicin—LRP2—Metabolism—PIK3CD—hematologic cancer	0.000161	0.000678	CbGpPWpGaD
Gentamicin—Nausea—Thalidomide—hematologic cancer	0.00016	0.00021	CcSEcCtD
Gentamicin—Rash—Ifosfamide—hematologic cancer	0.00016	0.00021	CcSEcCtD
Gentamicin—Dermatitis—Ifosfamide—hematologic cancer	0.00016	0.000209	CcSEcCtD
Gentamicin—Neuropathy peripheral—Doxorubicin—hematologic cancer	0.00016	0.000209	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—FN1—hematologic cancer	0.00016	0.000674	CbGpPWpGaD
Gentamicin—Dizziness—Irinotecan—hematologic cancer	0.000159	0.000209	CcSEcCtD
Gentamicin—Urticaria—Etoposide—hematologic cancer	0.000159	0.000209	CcSEcCtD
Gentamicin—Stomatitis—Doxorubicin—hematologic cancer	0.000159	0.000208	CcSEcCtD
Gentamicin—LRP2—Metabolism—ALB—hematologic cancer	0.000159	0.00067	CbGpPWpGaD
Gentamicin—Body temperature increased—Etoposide—hematologic cancer	0.000158	0.000208	CcSEcCtD
Gentamicin—Vertigo—Prednisone—hematologic cancer	0.000158	0.000207	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—BAD—hematologic cancer	0.000158	0.000666	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NFKBIA—hematologic cancer	0.000158	0.000666	CbGpPWpGaD
Gentamicin—Tinnitus—Methotrexate—hematologic cancer	0.000157	0.000206	CcSEcCtD
Gentamicin—Hypoaesthesia—Epirubicin—hematologic cancer	0.000157	0.000206	CcSEcCtD
Gentamicin—Vomiting—Vincristine—hematologic cancer	0.000157	0.000206	CcSEcCtD
Gentamicin—Urticaria—Prednisolone—hematologic cancer	0.000157	0.000206	CcSEcCtD
Gentamicin—LRP2—Disease—CDKN1B—hematologic cancer	0.000157	0.000663	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NOTCH1—hematologic cancer	0.000156	0.00066	CbGpPWpGaD
Gentamicin—Rash—Vincristine—hematologic cancer	0.000156	0.000204	CcSEcCtD
Gentamicin—Dermatitis—Vincristine—hematologic cancer	0.000156	0.000204	CcSEcCtD
Gentamicin—Headache—Vincristine—hematologic cancer	0.000155	0.000203	CcSEcCtD
Gentamicin—Hypotension—Dexamethasone—hematologic cancer	0.000154	0.000202	CcSEcCtD
Gentamicin—Hypotension—Betamethasone—hematologic cancer	0.000154	0.000202	CcSEcCtD
Gentamicin—Nausea—Carmustine—hematologic cancer	0.000154	0.000202	CcSEcCtD
Gentamicin—Vomiting—Irinotecan—hematologic cancer	0.000153	0.000201	CcSEcCtD
Gentamicin—Vomiting—Mitoxantrone—hematologic cancer	0.000153	0.000201	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CD80—hematologic cancer	0.000153	0.000646	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KIT—hematologic cancer	0.000153	0.000645	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CG—hematologic cancer	0.000153	0.000645	CbGpPWpGaD
Gentamicin—Nausea—Alitretinoin—hematologic cancer	0.000152	0.0002	CcSEcCtD
Gentamicin—Convulsion—Prednisone—hematologic cancer	0.000152	0.0002	CcSEcCtD
Gentamicin—Visual impairment—Epirubicin—hematologic cancer	0.000152	0.0002	CcSEcCtD
Gentamicin—Agranulocytosis—Doxorubicin—hematologic cancer	0.000152	0.000199	CcSEcCtD
Gentamicin—Hypertension—Prednisone—hematologic cancer	0.000152	0.000199	CcSEcCtD
Gentamicin—Rash—Irinotecan—hematologic cancer	0.000152	0.000199	CcSEcCtD
Gentamicin—Rash—Mitoxantrone—hematologic cancer	0.000152	0.000199	CcSEcCtD
Gentamicin—LRP2—Metabolism—PIK3R1—hematologic cancer	0.000152	0.000641	CbGpPWpGaD
Gentamicin—Dermatitis—Irinotecan—hematologic cancer	0.000152	0.000199	CcSEcCtD
Gentamicin—Dermatitis—Mitoxantrone—hematologic cancer	0.000152	0.000199	CcSEcCtD
Gentamicin—Headache—Irinotecan—hematologic cancer	0.000151	0.000198	CcSEcCtD
Gentamicin—Headache—Mitoxantrone—hematologic cancer	0.000151	0.000198	CcSEcCtD
Gentamicin—Nausea—Ifosfamide—hematologic cancer	0.000151	0.000197	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.00015	0.000197	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.00015	0.000197	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PTPN11—hematologic cancer	0.00015	0.000634	CbGpPWpGaD
Gentamicin—Arthralgia—Prednisone—hematologic cancer	0.00015	0.000196	CcSEcCtD
Gentamicin—Feeling abnormal—Triamcinolone—hematologic cancer	0.00015	0.000196	CcSEcCtD
Gentamicin—Alopecia—Methotrexate—hematologic cancer	0.000149	0.000196	CcSEcCtD
Gentamicin—Vomiting—Gemcitabine—hematologic cancer	0.000149	0.000195	CcSEcCtD
Gentamicin—Paraesthesia—Betamethasone—hematologic cancer	0.000148	0.000194	CcSEcCtD
Gentamicin—Paraesthesia—Dexamethasone—hematologic cancer	0.000148	0.000194	CcSEcCtD
Gentamicin—Rash—Gemcitabine—hematologic cancer	0.000148	0.000194	CcSEcCtD
Gentamicin—Dermatitis—Gemcitabine—hematologic cancer	0.000148	0.000194	CcSEcCtD
Gentamicin—Hypersensitivity—Etoposide—hematologic cancer	0.000148	0.000193	CcSEcCtD
Gentamicin—Tinnitus—Epirubicin—hematologic cancer	0.000147	0.000193	CcSEcCtD
Gentamicin—Erythema—Methotrexate—hematologic cancer	0.000147	0.000193	CcSEcCtD
Gentamicin—Headache—Gemcitabine—hematologic cancer	0.000147	0.000193	CcSEcCtD
Gentamicin—Nausea—Vincristine—hematologic cancer	0.000147	0.000193	CcSEcCtD
Gentamicin—Hypersensitivity—Prednisolone—hematologic cancer	0.000146	0.000191	CcSEcCtD
Gentamicin—Hypoaesthesia—Doxorubicin—hematologic cancer	0.000146	0.000191	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CREB1—hematologic cancer	0.000145	0.000614	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN1A—hematologic cancer	0.000145	0.000612	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTEN—hematologic cancer	0.000145	0.00061	CbGpPWpGaD
Gentamicin—Urticaria—Triamcinolone—hematologic cancer	0.000144	0.000189	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—BRAF—hematologic cancer	0.000144	0.000607	CbGpPWpGaD
Gentamicin—Body temperature increased—Triamcinolone—hematologic cancer	0.000144	0.000188	CcSEcCtD
Gentamicin—Anaphylactic shock—Prednisone—hematologic cancer	0.000144	0.000188	CcSEcCtD
Gentamicin—Decreased appetite—Dexamethasone—hematologic cancer	0.000143	0.000188	CcSEcCtD
Gentamicin—Decreased appetite—Betamethasone—hematologic cancer	0.000143	0.000188	CcSEcCtD
Gentamicin—Nausea—Mitoxantrone—hematologic cancer	0.000143	0.000187	CcSEcCtD
Gentamicin—Nausea—Irinotecan—hematologic cancer	0.000143	0.000187	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCL2—hematologic cancer	0.000142	0.000601	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL6R—hematologic cancer	0.000142	0.000599	CbGpPWpGaD
Gentamicin—Pruritus—Etoposide—hematologic cancer	0.000142	0.000186	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CREBBP—hematologic cancer	0.000142	0.000598	CbGpPWpGaD
Gentamicin—Visual impairment—Doxorubicin—hematologic cancer	0.000141	0.000185	CcSEcCtD
Gentamicin—LRP2—Metabolism—PIK3CB—hematologic cancer	0.00014	0.000591	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—ALB—hematologic cancer	0.00014	0.000591	CbGpPWpGaD
Gentamicin—Alopecia—Epirubicin—hematologic cancer	0.00014	0.000183	CcSEcCtD
Gentamicin—Nausea—Gemcitabine—hematologic cancer	0.000139	0.000183	CcSEcCtD
Gentamicin—Vomiting—Cisplatin—hematologic cancer	0.000139	0.000182	CcSEcCtD
Gentamicin—Rash—Cisplatin—hematologic cancer	0.000138	0.000181	CcSEcCtD
Gentamicin—LRP2—Disease—EP300—hematologic cancer	0.000138	0.000582	CbGpPWpGaD
Gentamicin—Dermatitis—Cisplatin—hematologic cancer	0.000138	0.000181	CcSEcCtD
Gentamicin—Erythema—Epirubicin—hematologic cancer	0.000138	0.00018	CcSEcCtD
Gentamicin—Tinnitus—Doxorubicin—hematologic cancer	0.000136	0.000179	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000136	0.000575	CbGpPWpGaD
Gentamicin—Anaemia—Methotrexate—hematologic cancer	0.000136	0.000178	CcSEcCtD
Gentamicin—Feeling abnormal—Betamethasone—hematologic cancer	0.000136	0.000178	CcSEcCtD
Gentamicin—Feeling abnormal—Dexamethasone—hematologic cancer	0.000136	0.000178	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—MAP2K1—hematologic cancer	0.000135	0.000571	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CD—hematologic cancer	0.000134	0.000567	CbGpPWpGaD
Gentamicin—LRP2—Disease—SRC—hematologic cancer	0.000134	0.000566	CbGpPWpGaD
Gentamicin—Hypersensitivity—Triamcinolone—hematologic cancer	0.000134	0.000175	CcSEcCtD
Gentamicin—Dizziness—Etoposide—hematologic cancer	0.000132	0.000174	CcSEcCtD
Gentamicin—Vertigo—Methotrexate—hematologic cancer	0.000132	0.000173	CcSEcCtD
Gentamicin—Leukopenia—Methotrexate—hematologic cancer	0.000132	0.000172	CcSEcCtD
Gentamicin—Urticaria—Dexamethasone—hematologic cancer	0.000131	0.000172	CcSEcCtD
Gentamicin—Urticaria—Betamethasone—hematologic cancer	0.000131	0.000172	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000131	0.000171	CcSEcCtD
Gentamicin—Dizziness—Prednisolone—hematologic cancer	0.000131	0.000171	CcSEcCtD
Gentamicin—Body temperature increased—Betamethasone—hematologic cancer	0.00013	0.000171	CcSEcCtD
Gentamicin—Body temperature increased—Dexamethasone—hematologic cancer	0.00013	0.000171	CcSEcCtD
Gentamicin—Nausea—Cisplatin—hematologic cancer	0.00013	0.00017	CcSEcCtD
Gentamicin—Alopecia—Doxorubicin—hematologic cancer	0.000129	0.000169	CcSEcCtD
Gentamicin—LRP2—Disease—STAT3—hematologic cancer	0.000129	0.000546	CbGpPWpGaD
Gentamicin—Paraesthesia—Prednisone—hematologic cancer	0.000129	0.000169	CcSEcCtD
Gentamicin—LRP2—Disease—NRAS—hematologic cancer	0.000129	0.000544	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGF2—hematologic cancer	0.000129	0.000543	CbGpPWpGaD
Gentamicin—Pruritus—Triamcinolone—hematologic cancer	0.000129	0.000168	CcSEcCtD
Gentamicin—Convulsion—Methotrexate—hematologic cancer	0.000127	0.000167	CcSEcCtD
Gentamicin—Vomiting—Etoposide—hematologic cancer	0.000127	0.000167	CcSEcCtD
Gentamicin—Erythema—Doxorubicin—hematologic cancer	0.000127	0.000167	CcSEcCtD
Gentamicin—Anaemia—Epirubicin—hematologic cancer	0.000127	0.000167	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PIK3R1—hematologic cancer	0.000127	0.000536	CbGpPWpGaD
Gentamicin—Rash—Etoposide—hematologic cancer	0.000126	0.000166	CcSEcCtD
Gentamicin—Dermatitis—Etoposide—hematologic cancer	0.000126	0.000165	CcSEcCtD
Gentamicin—Headache—Etoposide—hematologic cancer	0.000126	0.000164	CcSEcCtD
Gentamicin—Arthralgia—Methotrexate—hematologic cancer	0.000125	0.000164	CcSEcCtD
Gentamicin—Decreased appetite—Prednisone—hematologic cancer	0.000125	0.000164	CcSEcCtD
Gentamicin—Rash—Prednisolone—hematologic cancer	0.000125	0.000163	CcSEcCtD
Gentamicin—Dermatitis—Prednisolone—hematologic cancer	0.000124	0.000163	CcSEcCtD
Gentamicin—Headache—Prednisolone—hematologic cancer	0.000124	0.000162	CcSEcCtD
Gentamicin—Vertigo—Epirubicin—hematologic cancer	0.000124	0.000162	CcSEcCtD
Gentamicin—LRP2—Disease—MAPK3—hematologic cancer	0.000123	0.000521	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—JAK2—hematologic cancer	0.000123	0.000521	CbGpPWpGaD
Gentamicin—Leukopenia—Epirubicin—hematologic cancer	0.000123	0.000161	CcSEcCtD
Gentamicin—LRP2—Metabolism—PTEN—hematologic cancer	0.000121	0.000511	CbGpPWpGaD
Gentamicin—Confusional state—Methotrexate—hematologic cancer	0.000121	0.000159	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—MDM2—hematologic cancer	0.00012	0.000508	CbGpPWpGaD
Gentamicin—Dizziness—Triamcinolone—hematologic cancer	0.00012	0.000157	CcSEcCtD
Gentamicin—LRP2—Disease—MYC—hematologic cancer	0.00012	0.000507	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Methotrexate—hematologic cancer	0.00012	0.000157	CcSEcCtD
Gentamicin—LRP2—Disease—TGFB1—hematologic cancer	0.00012	0.000506	CbGpPWpGaD
Gentamicin—Convulsion—Epirubicin—hematologic cancer	0.000119	0.000156	CcSEcCtD
Gentamicin—Nausea—Etoposide—hematologic cancer	0.000119	0.000156	CcSEcCtD
Gentamicin—Hypertension—Epirubicin—hematologic cancer	0.000119	0.000156	CcSEcCtD
Gentamicin—Feeling abnormal—Prednisone—hematologic cancer	0.000118	0.000155	CcSEcCtD
Gentamicin—Anaemia—Doxorubicin—hematologic cancer	0.000118	0.000154	CcSEcCtD
Gentamicin—Thrombocytopenia—Methotrexate—hematologic cancer	0.000118	0.000154	CcSEcCtD
Gentamicin—Nausea—Prednisolone—hematologic cancer	0.000117	0.000154	CcSEcCtD
Gentamicin—Arthralgia—Epirubicin—hematologic cancer	0.000117	0.000154	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—MTOR—hematologic cancer	0.000117	0.000494	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CB—hematologic cancer	0.000117	0.000494	CbGpPWpGaD
Gentamicin—Pruritus—Betamethasone—hematologic cancer	0.000117	0.000153	CcSEcCtD
Gentamicin—Pruritus—Dexamethasone—hematologic cancer	0.000117	0.000153	CcSEcCtD
Gentamicin—Vomiting—Triamcinolone—hematologic cancer	0.000116	0.000151	CcSEcCtD
Gentamicin—LRP2—Metabolism—EP300—hematologic cancer	0.000115	0.000487	CbGpPWpGaD
Gentamicin—Rash—Triamcinolone—hematologic cancer	0.000115	0.00015	CcSEcCtD
Gentamicin—Dermatitis—Triamcinolone—hematologic cancer	0.000114	0.00015	CcSEcCtD
Gentamicin—Vertigo—Doxorubicin—hematologic cancer	0.000114	0.00015	CcSEcCtD
Gentamicin—Urticaria—Prednisone—hematologic cancer	0.000114	0.000149	CcSEcCtD
Gentamicin—Leukopenia—Doxorubicin—hematologic cancer	0.000114	0.000149	CcSEcCtD
Gentamicin—Headache—Triamcinolone—hematologic cancer	0.000114	0.000149	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000114	0.00048	CbGpPWpGaD
Gentamicin—Body temperature increased—Prednisone—hematologic cancer	0.000114	0.000149	CcSEcCtD
Gentamicin—Confusional state—Epirubicin—hematologic cancer	0.000113	0.000148	CcSEcCtD
Gentamicin—Anaphylactic shock—Epirubicin—hematologic cancer	0.000112	0.000147	CcSEcCtD
Gentamicin—Hypotension—Methotrexate—hematologic cancer	0.000112	0.000147	CcSEcCtD
Gentamicin—LRP2—Disease—KRAS—hematologic cancer	0.000111	0.000469	CbGpPWpGaD
Gentamicin—Convulsion—Doxorubicin—hematologic cancer	0.00011	0.000145	CcSEcCtD
Gentamicin—Thrombocytopenia—Epirubicin—hematologic cancer	0.00011	0.000144	CcSEcCtD
Gentamicin—Hypertension—Doxorubicin—hematologic cancer	0.00011	0.000144	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CDKN1B—hematologic cancer	0.00011	0.000464	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	0.000109	0.000143	CcSEcCtD
Gentamicin—Dizziness—Betamethasone—hematologic cancer	0.000109	0.000143	CcSEcCtD
Gentamicin—Dizziness—Dexamethasone—hematologic cancer	0.000109	0.000143	CcSEcCtD
Gentamicin—Arthralgia—Doxorubicin—hematologic cancer	0.000108	0.000142	CcSEcCtD
Gentamicin—Nausea—Triamcinolone—hematologic cancer	0.000108	0.000141	CcSEcCtD
Gentamicin—Paraesthesia—Methotrexate—hematologic cancer	0.000108	0.000141	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CASP3—hematologic cancer	0.000108	0.000455	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL2—hematologic cancer	0.000108	0.000454	CbGpPWpGaD
Gentamicin—Hypersensitivity—Prednisone—hematologic cancer	0.000106	0.000139	CcSEcCtD
Gentamicin—Hypotension—Epirubicin—hematologic cancer	0.000105	0.000138	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCND1—hematologic cancer	0.000105	0.000443	CbGpPWpGaD
Gentamicin—Vomiting—Dexamethasone—hematologic cancer	0.000105	0.000137	CcSEcCtD
Gentamicin—Vomiting—Betamethasone—hematologic cancer	0.000105	0.000137	CcSEcCtD
Gentamicin—Confusional state—Doxorubicin—hematologic cancer	0.000105	0.000137	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—JUN—hematologic cancer	0.000105	0.000442	CbGpPWpGaD
Gentamicin—Decreased appetite—Methotrexate—hematologic cancer	0.000104	0.000137	CcSEcCtD
Gentamicin—Rash—Betamethasone—hematologic cancer	0.000104	0.000136	CcSEcCtD
Gentamicin—Rash—Dexamethasone—hematologic cancer	0.000104	0.000136	CcSEcCtD
Gentamicin—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000104	0.000136	CcSEcCtD
Gentamicin—Dermatitis—Dexamethasone—hematologic cancer	0.000104	0.000136	CcSEcCtD
Gentamicin—Dermatitis—Betamethasone—hematologic cancer	0.000104	0.000136	CcSEcCtD
Gentamicin—Headache—Betamethasone—hematologic cancer	0.000103	0.000135	CcSEcCtD
Gentamicin—Headache—Dexamethasone—hematologic cancer	0.000103	0.000135	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	0.000102	0.000134	CcSEcCtD
Gentamicin—LRP2—Disease—PIK3CA—hematologic cancer	0.000102	0.00043	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Doxorubicin—hematologic cancer	0.000102	0.000133	CcSEcCtD
Gentamicin—Pruritus—Prednisone—hematologic cancer	0.000102	0.000133	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CDKN1A—hematologic cancer	0.000101	0.000428	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTEN—hematologic cancer	0.000101	0.000427	CbGpPWpGaD
Gentamicin—Paraesthesia—Epirubicin—hematologic cancer	0.000101	0.000132	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—MAPK8—hematologic cancer	9.9e-05	0.000418	CbGpPWpGaD
Gentamicin—Feeling abnormal—Methotrexate—hematologic cancer	9.89e-05	0.00013	CcSEcCtD
Gentamicin—Nausea—Betamethasone—hematologic cancer	9.79e-05	0.000128	CcSEcCtD
Gentamicin—Nausea—Dexamethasone—hematologic cancer	9.79e-05	0.000128	CcSEcCtD
Gentamicin—Decreased appetite—Epirubicin—hematologic cancer	9.76e-05	0.000128	CcSEcCtD
Gentamicin—Hypotension—Doxorubicin—hematologic cancer	9.71e-05	0.000127	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—EP300—hematologic cancer	9.65e-05	0.000407	CbGpPWpGaD
Gentamicin—Urticaria—Methotrexate—hematologic cancer	9.53e-05	0.000125	CcSEcCtD
Gentamicin—Dizziness—Prednisone—hematologic cancer	9.5e-05	0.000124	CcSEcCtD
Gentamicin—Body temperature increased—Methotrexate—hematologic cancer	9.49e-05	0.000124	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	9.47e-05	0.000124	CcSEcCtD
Gentamicin—LRP2—Disease—HRAS—hematologic cancer	9.43e-05	0.000398	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SRC—hematologic cancer	9.39e-05	0.000396	CbGpPWpGaD
Gentamicin—Paraesthesia—Doxorubicin—hematologic cancer	9.33e-05	0.000122	CcSEcCtD
Gentamicin—Feeling abnormal—Epirubicin—hematologic cancer	9.26e-05	0.000121	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—VEGFA—hematologic cancer	9.14e-05	0.000386	CbGpPWpGaD
Gentamicin—Vomiting—Prednisone—hematologic cancer	9.13e-05	0.00012	CcSEcCtD
Gentamicin—Rash—Prednisone—hematologic cancer	9.05e-05	0.000119	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—STAT3—hematologic cancer	9.05e-05	0.000382	CbGpPWpGaD
Gentamicin—Dermatitis—Prednisone—hematologic cancer	9.05e-05	0.000119	CcSEcCtD
Gentamicin—Decreased appetite—Doxorubicin—hematologic cancer	9.03e-05	0.000118	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—NRAS—hematologic cancer	9.03e-05	0.000381	CbGpPWpGaD
Gentamicin—LRP2—Disease—IL6—hematologic cancer	9.03e-05	0.000381	CbGpPWpGaD
Gentamicin—Headache—Prednisone—hematologic cancer	9e-05	0.000118	CcSEcCtD
Gentamicin—Urticaria—Epirubicin—hematologic cancer	8.92e-05	0.000117	CcSEcCtD
Gentamicin—Body temperature increased—Epirubicin—hematologic cancer	8.88e-05	0.000116	CcSEcCtD
Gentamicin—Hypersensitivity—Methotrexate—hematologic cancer	8.84e-05	0.000116	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—MAPK3—hematologic cancer	8.65e-05	0.000365	CbGpPWpGaD
Gentamicin—Feeling abnormal—Doxorubicin—hematologic cancer	8.56e-05	0.000112	CcSEcCtD
Gentamicin—LRP2—Metabolism—PIK3CA—hematologic cancer	8.54e-05	0.00036	CbGpPWpGaD
Gentamicin—Nausea—Prednisone—hematologic cancer	8.53e-05	0.000112	CcSEcCtD
Gentamicin—Pruritus—Methotrexate—hematologic cancer	8.49e-05	0.000111	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—MYC—hematologic cancer	8.41e-05	0.000355	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TGFB1—hematologic cancer	8.39e-05	0.000354	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT1—hematologic cancer	8.33e-05	0.000352	CbGpPWpGaD
Gentamicin—Hypersensitivity—Epirubicin—hematologic cancer	8.27e-05	0.000108	CcSEcCtD
Gentamicin—Urticaria—Doxorubicin—hematologic cancer	8.26e-05	0.000108	CcSEcCtD
Gentamicin—Body temperature increased—Doxorubicin—hematologic cancer	8.22e-05	0.000108	CcSEcCtD
Gentamicin—Pruritus—Epirubicin—hematologic cancer	7.95e-05	0.000104	CcSEcCtD
Gentamicin—Dizziness—Methotrexate—hematologic cancer	7.94e-05	0.000104	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—KRAS—hematologic cancer	7.77e-05	0.000328	CbGpPWpGaD
Gentamicin—Hypersensitivity—Doxorubicin—hematologic cancer	7.66e-05	0.0001	CcSEcCtD
Gentamicin—Vomiting—Methotrexate—hematologic cancer	7.63e-05	0.0001	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.6e-05	0.000321	CbGpPWpGaD
Gentamicin—Rash—Methotrexate—hematologic cancer	7.57e-05	9.92e-05	CcSEcCtD
Gentamicin—Dermatitis—Methotrexate—hematologic cancer	7.56e-05	9.91e-05	CcSEcCtD
Gentamicin—Headache—Methotrexate—hematologic cancer	7.52e-05	9.85e-05	CcSEcCtD
Gentamicin—Dizziness—Epirubicin—hematologic cancer	7.43e-05	9.73e-05	CcSEcCtD
Gentamicin—Pruritus—Doxorubicin—hematologic cancer	7.35e-05	9.63e-05	CcSEcCtD
Gentamicin—Vomiting—Epirubicin—hematologic cancer	7.14e-05	9.36e-05	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PIK3CA—hematologic cancer	7.14e-05	0.000301	CbGpPWpGaD
Gentamicin—Nausea—Methotrexate—hematologic cancer	7.13e-05	9.34e-05	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	7.11e-05	0.0003	CbGpPWpGaD
Gentamicin—Rash—Epirubicin—hematologic cancer	7.08e-05	9.28e-05	CcSEcCtD
Gentamicin—Dermatitis—Epirubicin—hematologic cancer	7.07e-05	9.27e-05	CcSEcCtD
Gentamicin—Headache—Epirubicin—hematologic cancer	7.04e-05	9.22e-05	CcSEcCtD
Gentamicin—LRP2—Metabolism—AKT1—hematologic cancer	6.98e-05	0.000294	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—hematologic cancer	6.91e-05	0.000292	CbGpPWpGaD
Gentamicin—Dizziness—Doxorubicin—hematologic cancer	6.87e-05	9e-05	CcSEcCtD
Gentamicin—Nausea—Epirubicin—hematologic cancer	6.67e-05	8.74e-05	CcSEcCtD
Gentamicin—Vomiting—Doxorubicin—hematologic cancer	6.61e-05	8.66e-05	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HRAS—hematologic cancer	6.61e-05	0.000279	CbGpPWpGaD
Gentamicin—Rash—Doxorubicin—hematologic cancer	6.55e-05	8.59e-05	CcSEcCtD
Gentamicin—Dermatitis—Doxorubicin—hematologic cancer	6.55e-05	8.58e-05	CcSEcCtD
Gentamicin—Headache—Doxorubicin—hematologic cancer	6.51e-05	8.53e-05	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—IL6—hematologic cancer	6.32e-05	0.000267	CbGpPWpGaD
Gentamicin—Nausea—Doxorubicin—hematologic cancer	6.17e-05	8.09e-05	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—AKT1—hematologic cancer	5.83e-05	0.000246	CbGpPWpGaD
